☆ 4.7 Article

6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor

JOURNAL OF MEDICINAL CHEMISTRY (2010)

Journal

JOURNAL OF MEDICINAL CHEMISTRY

Volume 53, Issue 13, Pages 4989-5001

Publisher

AMER CHEMICAL SOC

DOI: 10.1021/jm100481d

Keywords

-

Categories

Chemistry, Medicinal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

A pharmacophore model for triple reuptake inhibitors and the new class of 1-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes were recently reported. Further investigation in this area led to the identification of a new series of potent and selective triple reuptake inhibitors endowed with good developability characteristics. Excellent bioavailability and brain penetration are associated with this series of 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptanes together with high in vitro potency and selectivity at SERT, NET, and DAT. In vivo microdialysis experiments in different animal models and receptor occupancy studies in rat confirmed that derivative 17 showed an appropriate profile to further progression of the compound.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Chemistry, Organic

Synthesis of γ-Aminobutyric Acid (GABA) Analogues Conformationally Restricted by Bicyclo[3.1.0]hexane/hexene or [4.1.0]Heptane/heptene Backbones as Potent Betaine/GABA Transporter Inhibitors

Keisuke Mitsui, Maria E. K. Lie, Naoki Saito, Koichi Fujiwara, Mizuki Watanabe, Petrine Wellendorph, Satoshi Shuto

Summary: Novel gamma-aminobutyric acid (GABA) analogues with different backbones were designed based on the analysis of the bioactive form of a previous inhibitor. These compounds were synthesized using ring-closing metathesis and compound 4 showed selective low micromolar potency.

ORGANIC LETTERS (2022)

Add to Collection

Article Chemistry, Medicinal

Discovery of 6-[(3S,4S)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 Inhibitor

Barbara Czako, Yuting Sun, Timothy McAfoos, Jason B. Cross, Paul G. Leonard, Jason P. Burke, Christopher L. Carroll, Ningping Feng, Angela L. Harris, Yongying Jiang, Zhijun Kang, Jeffrey J. Kovacs, Pijus Mandal, Brooke A. Meyers, Faika Mseeh, Connor A. Parker, Simon S. Yu, Christopher C. Williams, Qi Wu, Maria Emilia Di Francesco, Giulio Draetta, Timothy Heffernan, Joseph R. Marszalek, Nancy E. Kohl, Philip Jones

Summary: The search for potent compounds interfering with the function of SHP2 led to the discovery of a series of pyrimidinone compounds with high potency and narrow hERG window in humans, showing potential for targeted therapies in cancers driven by RTK and KRAS mutations.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Chemistry, Medicinal

Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast Cancer

Carine M. Abdelmalek, Zexi Hu, Thales Kronenberger, Jenni Kublbeck, Franziska J. M. Kinnen, Salma S. Hesse, Afsin Malik, Mark Kudolo, Raimund Niess, Matthias Gehringer, Lars Zender, Paula A. Witt-Enderby, Darius P. Zlotos, Stefan A. Laufer

Summary: Anticancer drug conjugates that simultaneously target two receptors may overcome the limitations of current cancer treatments. A series of compounds connecting tamoxifen or endoxifen with the EGFR-inhibitor gefitinib exhibit potent anticancer activity in breast cancer cells.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Novel Potent Dopamine-Norepinephrine and Triple Reuptake Uptake Inhibitors Based on Asymmetric Pyran Template and Their Molecular Interactions with Monoamine Transporters

Soumava Santra, Sandhya Kortagere, Seenuvasan Vedachalam, Sanjib Gogoi, Tamara Antonio, Maarten E. A. Reith, Aloke K. Dutta

Summary: The study revealed a significant influence from the alteration of the stereochemistry of the hydroxyl group on the pyran ring of D-473 on transporters affinities, indicating stereospecific preference for interaction. Furthermore, novel compounds such as D-528 and D-529 were identified as some of the most potent dopamine-norepinephrine reuptake inhibitors known to-date. Computational analysis found that the nature of interactions from molecular docking experiments correlated well with the affinities of the compounds for the transporters.

ACS CHEMICAL NEUROSCIENCE (2021)

Add to Collection

Article Chemistry, Medicinal

Discovery and Optimization of a Novel 2H-Pyrazolo[3,4-d]pyrimidine Derivative as a Potent Irreversible Pan-Fibroblast Growth Factor Receptor Inhibitor

Yujiao Wei, Yanting Tang, Yunyun Zhou, Yuyu Yang, Yetong Cui, Xuan Wang, Yubo Wang, Yulin Liu, Ning Liu, Qianqian Wang, Chong Li, Hao Ruan, Honggang Zhou, Mingming Wei, Guang Yang, Cheng Yang

Summary: The study identified a novel lead compound 36 with significant inhibitory effects against FGFR (1-3) and demonstrated low toxicity and adequate pharmacokinetic properties. Compound 36 also showed significant anti-proliferation effects against cancer cell lines NCI-H1581 and SNU-16, making it a potential drug candidate under validation.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Chemistry, Physical

Structural (monomer and dimer), wavefunctional, NCI analysis in aqueous phase, electronic and excited state properties in different solvent atmosphere of 3-{(E)-[(3,4-dichlorophenyl)imino]methyl}benzene-1,2-diol

M. Maria Julie, T. Prabhu, E. Elamuruguporchelvi, Fazilath Basha Asif, S. Muthu, Ahmad Irfan

Summary: This study utilized Gaussian 16W density functional theory to investigate the structural, wave functional, and electronic properties of a specific compound. Various properties such as optimized geometrical properties, wave functional characteristics, band gap energies, reactive sites, excited energies, and molecular interactions were analyzed using different computational methods. Spectroscopic wave numbers were predicted and biological activities were explored through molecular docking study.

JOURNAL OF MOLECULAR LIQUIDS (2021)

Add to Collection

Article Chemistry, Physical

Identification of (S)-10-Hydroxycamptothecin as a potent BRD4 inhibitor for treating triple-negative breast cancer

Pilei Si, Haijun Chen, Jiquan Liu, Enzhao Zhang, Chengzhen Li, Jiaojiao Gu, Ruoyan Wang, Wentao Li

Summary: In this study, a potent BRD4 inhibitor, 10-HCPT, was identified for the treatment of triple-negative breast cancer (TNBC). The results showed that 10-HCPT can inhibit the growth of TNBC cells by binding to BRD4 and inducing apoptosis. The study also provided new insights into the potential use of 10-HCPT as a therapy for TNBC.

JOURNAL OF MOLECULAR STRUCTURE (2022)

Add to Collection

Article Multidisciplinary Sciences

Synthesis, antimicrobial and molecular docking study of structural analogues of 3-((5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

Saharish Khaliq, Mohsin Abbas Khan, Irshad Ahmad, Imtiaz Ahmad, Javed Ahmed, Farhat Ullah

Summary: The goal of this work was to create structural analogues of a beta lactam antibiotic to combat bacterial resistant strains. The spectroscopic study on compounds M1-8 using FTIR, H-1 NMR, C-13 NMR, and CHNS analyses showed that two molecules, M-2 and M-3, had stronger antibacterial activity. The findings are significant for the search for effective drugs against antibiotic-resistant bacteria.

PLOS ONE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Design, synthesis and biological evaluation of novel 5-methyl-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives as potent potassium-competitive acid blockers

Xianlian Wang, Yongmei Xu, Zaiwei Zong, Jinna Cai, Chunlin Chen, Qingwei Zhang, Xun Sun, Jianqi Li

Summary: A series of 5-methyl-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives were synthesized and evaluated for their potential as a novel potent potassium-competitive acid blocker (P-CAB) agent. Compound 3-((3-(2-fluorophenyl)-5-methyl-5,6-dihydropyrrolo[3,4-c]pyrazol-2(4H)-yl)methyl)-[1,1'-biphenyl]-3-carboxamide showed promising inhibitory activity and potential as a P-CAB agent for further investigation.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Chemistry, Medicinal

Synthesis and biological evaluation of N-(3-fluorobenzyl)-4-(1-(methyl-d3)-1H-indazol-5-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-amine as a novel, potent ALK5 receptor inhibitor

Byung-Nam Kang, Hong-Jun Kang, Sunjoo Kim, Jungwoo Lee, Jinwoo Lee, Hee-Jin Jeong, Seeun Jeon, Youngdo Shin, Cheolhwan Yoon, Cheolkyu Han, Jeongbeob Seo, Jaesook Yun

Summary: Specific inhibition of ALK5 can control the development of cancers and fibrotic diseases effectively. In this study, a potential clinical candidate, N-(3-fluorobenzyl)-4-(1-(methyl-d3)-1H-indazol-5-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-amine (11), was synthesized by incorporating deuterium at potential metabolic soft spots and identified as an ALK5 inhibitor.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2023)

Add to Collection

Article Cell Biology

N-(3,4-dimethoxyphenethyl)-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine inhibits bladder cancer progression by suppressing YAP1/TAZ

Yusuke Shiraishi, Tomohiko Maehama, Miki Nishio, Junji Otani, Hiroki Hikasa, Tak Wah Mak, Takehiko Sasaki, Teruki Honma, Yasumitsu Kondoh, Hiroyuki Osada, Minoru Yoshida, Masato Fujisawa, Akira Suzuki

Summary: DMPCA has been found to suppress the viability of BlC cells by inducing the phosphorylation of LATS1 and YAP1/TAZ, showing potential anti-tumor effects.

GENES TO CELLS (2022)

Add to Collection

Article Chemistry, Medicinal

Discovery of N-((3S,4S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity

Jinxin Che, Xiaoyang Dai, Jian Gao, Haichao Sheng, Wenhu Zhan, Yang Lu, Dan Li, Zizheng Gao, Zegao Jin, Binhui Chen, Peihua Luo, Bo Yang, Yongzhou Hu, Qiaojun He, Qinjie Weng, Xiaowu Dong

Summary: Inhibiting Akt2 isozyme may lead to keratinocyte apoptosis, driving the search for new selective Akt inhibitors with improved cutaneous safety. After optimization, Hu7691 shows promising selectivity, low apoptosis induction in keratinocytes, and excellent anticancer cell proliferation potency, leading to its approval by NMPA for clinical trials.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Chemistry, Organic

Synthesis and Evaluation of 3-(Indol-3-yl)-4-(pyrazolo[3,4-c]pyridazin-3-yl)maleimides as Potent Mutant Isocitrate Dehydrogenase-1 Inhibitors

Meng Xu, Shenyuan Gao, Yuanxu Zeng, Anhui Gao, Lixin Gao, Lei Xu, Yubo Zhou, Jianrong Gao, Qing Ye, Jia Li

Summary: A series of novel maleimide compounds were synthesized and evaluated for their inhibitory activity against mutant isocitrate dehydrogenase-1 (R132H), with compound 9b showing the most promising results. It was found that compound 9b could significantly inhibit the production of 2-HG.

CHINESE JOURNAL OF ORGANIC CHEMISTRY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Synthesis and Evaluation of a 3,4-dihydro-2H-benzoxazine Derivative as a Potent CDK9 Inhibitor for Anticancer Therapy

Taehun Song, Moonsub Lee, Inhwan Bae, Joo-Yun Byun, Young Gil Ahn, Young Hoon Kim, Young-Jin Chun

Summary: Cyclin-dependent kinase (CDK) 9 is a key regulator in transcription process and a potential target for cancer therapy. Compound 8 has been shown to exhibit potent CDK9 inhibitory activity and potential antitumor efficacy in mouse models, holding promise as a highly potent CDK9 inhibitor for anticancer approaches.

BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2021)

Add to Collection

Article Medicine, Research & Experimental

XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer

Shan Xu, Xin Sun, Leixuan Luo, Yang Yang, Qiuyan Guo, Sheng Tang, Zhiyan Jiang, Yuzhen Li, Jiaqian Han, Wenhui Gan, Feiyi Yang, Xuan Zhang, Yijun Liu, Chuanchuan Sun, Jie He, Meng Liu, Daiying Zuo, Wufu Zhu, Yingliang Wu

Summary: Breast cancer has become the most commonly diagnosed cancer and there is an urgent need for effective therapeutic drugs. In this study, a novel drug XS-2 was designed and synthesized, showing potent anti-tumor activity against breast cancer cells, particularly triple-negative breast cancer (TNBC). XS-2 exhibited strong inhibitory effects on cancer cells both in vitro and in vivo, with low toxicity. Furthermore, XS-2 was found to inhibit cell invasion and migration. These findings suggest that XS-2 has the potential to be developed as a high-efficiency and low-toxicity therapeutic drug for TNBC.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists

Fabrizio Micheli, Andrea Bernardelli, Federica Bianchi, Simone Braggio, Laura Castelletti, Palmina Cavallini, Paolo Cavanni, Susanna Cremonesi, Michele Dal Cin, Aldo Feriani, Beatrice Oliosi, Teresa Semeraro, Luca Tarsi, Silvia Tomelleri, Andrea Wong, Filippo Visentini, Laura Zonzini, Christian Heidbreder

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

Add to Collection

Article Chemistry, Medicinal

Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists

Fabrizio Micheli, Susanna Cremonesi, Teresa Semeraro, Luca Tarsi, Silvia Tomelleri, Paolo Cavanni, Beatrice Oliosi, Elisabetta Perdona, Anna Sava, Laura Zonzini, Aldo Feriani, Simone Braggio, Christian Heidbreder

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Add to Collection

Article Chemistry, Medicinal

1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists

Fabrizio Micheli, Alessia Bacchi, Simone Braggio, Laura Castelletti, Palmina Cavallini, Paolo Cavanni, Susanna Cremonesi, Michele Dal Cin, Aldo Feriani, Sylvie Gehanne, Mahmud Kajbaf, Luciano Marchio, Selena Nola, Beatrice Oliosi, Annalisa Pellacani, Elisabetfa Perdona, Anna Sava, Teresa Semeraro, Luca Tarsi, Silvia Tomelleri, Andrea Wong, Filippo Visentini, Laura Zonzini, Christian Heidbreder

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors

Fabrizio Micheli, Paolo Cavanni, Michela Bettati, Giorgio Bonanomi, Romano Di Fabio, Elettra Fazzolari, Carla Marchioro, Maja Roscic, Luca Tarsi, Filippo Visentini, Laura Zonzini, Angela Worby

BIOORGANIC & MEDICINAL CHEMISTRY (2011)

Add to Collection

Article Biochemistry & Molecular Biology

Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate

Romano Di Fabio, Giuseppe Alvaro, Simone Braggio, Renzo Carletti, Philip A. Gerrard, Cristiana Griffante, Carla Marchioro, Alfonso Pozzan, Sergio Melotto, Alessandro Poffe, Laura Piccoli, Emiliangelo Ratti, Elvira Tranquillini, Michael Trower, Simone Spada, Mauro Corsi

BIOORGANIC & MEDICINAL CHEMISTRY (2013)

Add to Collection

Article Chemistry, Medicinal

Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders

Romano Di Fabio, Annalisa Pellacani, Stefania Faedo, Adelheid Roth, Laura Piccoli, Philip Gerrard, Rod A. Porter, Christopher N. Johnson, Kevin Thewlis, Daniele Donati, Luigi Stasi, Simone Spada, Geoffrey Stemp, David Nash, Clive Branch, Leanda Kindon, Mario Massagrande, Alessandro Poffe, Simone Braggio, Elisabetta Chiarparin, Carla Marchioro, Emiliangelo Ratti, Mauro Corsi

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Add to Collection

Article Chemistry, Medicinal

Targeting Cystalysin, a Virulence Factor of Treponema denticola-Supported Periodontitis

Francesca Spyrakis, Barbara Cellini, Stefano Bruno, Paolo Benedetti, Emanuele Carosati, Gabriele Cruciani, Fabrizio Micheli, Antonio Felici, Pietro Cozzini, Glen E. Kellogg, Carla Borri Voltattorni, Andrea Mozzarelli

CHEMMEDCHEM (2014)

Add to Collection

Review Chemistry, Medicinal

Dopamine D3 receptor antagonists: a patent review (2007-2012)

Fabrizio Micheli, Christian Heidbreder

EXPERT OPINION ON THERAPEUTIC PATENTS (2013)

Add to Collection

Article Chemistry, Medicinal

Further Insights in 5-phenyl-2-[2-(1-piperidinylcarbonyl) Phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones, a Recently Disclosed Class of Neuropeptide S Antagonists

Gabriele Costantino, Marco Mor, Chiara Pecchini, Gian Paolo Vallerini, Elisa Della Turca, Fabrizio Micheli, Angela Worby, Romano Di Fabio, Angelo Giacometti, Adelheid Roth, Emilio Merlo-Pich, Matteo Biagetti, Giorgio Bonanomi, Dino Montanari, Luca Tarsi, Federica Tonelli, Raffaele Longhi, Anna Maria Capelli

LETTERS IN DRUG DESIGN & DISCOVERY (2013)

Add to Collection

Article Neurosciences

Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach

Manolo Mugnaini, Laura Iavarone, Palmina Cavallini, Cristiana Griffante, Beatrice Oliosi, Chiara Savoia, John Beaver, Eugenii A. Rabiner, Fabrizio Micheli, Christian Heidbreder, Anne Andorn, Emilio Merlo Pich, Massimo Bani

NEUROPSYCHOPHARMACOLOGY (2013)

Add to Collection

Article Chemistry, Organic

Regioselective synthesis of 1,3,5- and 1,3,4,5-substituted pyrazoles via acylation of N-Boc-N-substituted hydrazones

Alessandro Tinarelli, Paolo Righi, Goffredo Rosini, Daniele Andreotti, Roberto Profeta, Simone Spada

TETRAHEDRON (2011)

Add to Collection

Article Chemistry, Medicinal

Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems

Alessandro Grillo, Giulia Chemi, Simone Brogi, Margherita Brindisi, Nicola Relitti, Filomena Fezza, Domenico Fazio, Laura Castelletti, Elisabetta Perdona, Andrea Wong, Stefania Lamponi, Alessandra Pecorelli, Mascia Benedusi, Manuela Fantacci, Massimo Valoti, Giuseppe Valacchi, Fabrizio Micheli, Ettore Novellino, Giuseppe Campiani, Stefania Butini, Mauro Maccarrone, Sandra Gemma

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Chemistry, Applied

Implementing Continuous Manufacturing for the Final Methylation Step in the AMG 397 Process to Deliver Key Quality Attributes

Janine K. Tom, Michal M. Achmatowicz, Matthew G. Beaver, John Colyer, Ari Ericson, Tsang-Lin Hwang, Nancy Jiao, Neil F. Langille, Min Liu, Michael A. Lovette, Rahul P. Sangodkar, Srividya Sharvan Kumar, Simone Spada, Damith Perera, Jillian Sheeran, Kiersten Campbell, Timothy Doherty, David D. Ford, Yuan-Qing Fang, Emiliano Rossi, Gabriella Santoni, Sheng Cui, Shawn D. Walker

Summary: This article discusses process development efforts to improve the final methylation step in the AMG 397 drug substance process, culminating in the execution of a Good Manufacturing Practice (GMP) continuous manufacturing process. Through batch kinetic studies and detailed NMR analysis, the critical factors for consistent reaction conversion and obtaining high purity API were identified. Lessons learned from the manufacturing campaign resulted in the development of a second-generation continuous process, which successfully demonstrated improved reaction processing on a 100 g scale.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2021)

Add to Collection

Article Chemistry, Medicinal

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified Amino Region

Fabrizio Micheli

CHEMMEDCHEM (2017)

Add to Collection

Review Pharmacology & Pharmacy

Triple monoamine uptake inhibitors

Anna Maria Capelli, Fabrizio Micheli

PHARMACEUTICAL PATENT ANALYST (2012)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.